Sales rise 36.90% to Rs 23.26 crore
Net profit of Jenburkt Pharmaceuticals reported to Rs 2.70 crore in the quarter ended June 2018 as against net loss of Rs 2.88 crore during the previous quarter ended June 2017. Sales rose 36.90% to Rs 23.26 crore in the quarter ended June 2018 as against Rs 16.99 crore during the previous quarter ended June 2017. ParticularsQuarter EndedJun. 2018Jun. 2017% Var.Sales23.2616.99 37 OPM %11.18-21.01 -PBDT3.42-2.55 LP PBT3.10-2.91 LP NP2.70-2.88 LPPowered by Capital Market - Live News